Tower Research Capital (TRC)’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$52.4K Sell
10,341
-17,203
-62% -$87.2K ﹤0.01% 2931
2025
Q1
$83.2K Sell
27,544
-5,312
-16% -$16K ﹤0.01% 1877
2024
Q4
$119K Buy
32,856
+19,316
+143% +$69.9K ﹤0.01% 2059
2024
Q3
$23.8K Sell
13,540
-13,798
-50% -$24.3K ﹤0.01% 3143
2024
Q2
$42.6K Buy
27,338
+21,071
+336% +$32.9K ﹤0.01% 3220
2024
Q1
$12.2K Buy
+6,267
New +$12.2K ﹤0.01% 3498
2023
Q4
Sell
-682
Closed -$1.08K 6214
2023
Q3
$1.08K Buy
682
+471
+223% +$744 ﹤0.01% 5411
2023
Q2
$456 Sell
211
-1,070
-84% -$2.31K ﹤0.01% 5611
2023
Q1
$3K Sell
1,281
-16,162
-93% -$37.9K ﹤0.01% 5259
2022
Q4
$38K Sell
17,443
-23,522
-57% -$51.2K ﹤0.01% 2551
2022
Q3
$123K Buy
40,965
+19,150
+88% +$57.5K ﹤0.01% 2387
2022
Q2
$62K Buy
21,815
+20,792
+2,032% +$59.1K ﹤0.01% 2690
2022
Q1
$5K Buy
1,023
+998
+3,992% +$4.88K ﹤0.01% 5125
2021
Q4
$0 Sell
25
-656
-96% ﹤0.01% 6644
2021
Q3
$6K Buy
681
+493
+262% +$4.34K ﹤0.01% 4784
2021
Q2
$1K Sell
188
-15,063
-99% -$80.1K ﹤0.01% 5274
2021
Q1
$68K Buy
15,251
+12,413
+437% +$55.3K ﹤0.01% 2875
2020
Q4
$11K Buy
2,838
+1,819
+179% +$7.05K ﹤0.01% 4265
2020
Q3
$4K Buy
+1,019
New +$4K ﹤0.01% 4448
2020
Q1
Sell
-1,806
Closed -$8K 4040
2019
Q4
$8K Sell
1,806
-4,181
-70% -$18.5K ﹤0.01% 2470
2019
Q3
$21K Buy
+5,987
New +$21K ﹤0.01% 2453
2019
Q1
Sell
-7
Closed 4352
2018
Q4
$0 Buy
+7
New ﹤0.01% 4450
2018
Q2
Sell
-1,068
Closed -$40K 4123
2018
Q1
$40K Buy
1,068
+227
+27% +$8.5K ﹤0.01% 1799
2017
Q4
$41K Buy
+841
New +$41K 0.01% 1487
2017
Q1
Sell
-80
Closed -$2K 4046
2016
Q4
$2K Sell
80
-28
-26% -$700 ﹤0.01% 3481
2016
Q3
$4K Sell
108
-100
-48% -$3.7K ﹤0.01% 2730
2016
Q2
$8K Buy
+208
New +$8K ﹤0.01% 3046
2016
Q1
Hold
0
5070
2015
Q4
Sell
-87
Closed -$12K 5154
2015
Q3
$12K Buy
87
+82
+1,640% +$11.3K ﹤0.01% 2176
2015
Q2
$1K Buy
+5
New +$1K ﹤0.01% 4103